,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny04', 'bcsm']
this destiny04 standing ovation was quite a roar! #asco22 #bcsm 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.